Skip to content

ExMediKA

Active
Private limited companyfounded 2022active for 4 yearsDrève des Arches 17, 5340 Gesves, BelgiumKBO/BCE: BE 0785.643.679
Summary

ExMediKA has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €275,693 and a net result of €94,786. Equity is growing by about 52% per year across the filed financial years. Its solvency ranks better than 73% of 4,298 sector peers (NACE 74, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Other professional, scientific and technical activities
NACE 74999
1 site
Size
€382,568total assets 2025
Equity
€275,693
Profit
€94,786
Turnover not published (micro format)
Financial health
97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Accounts on time0 of 1 deed read
Why 97lowers riskSector: Other professional, scientific and technical activities (NACE 74)Liquidity: current ratio 3.75, cash €83,262Equity €275,693 (72.1% of total assets)Size: total assets €382,568Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 72% of its sector peers (NACE 74, micro)
Financial strength · tick = 2024
Strong
Solvency 97+7
equity 72.1% of total assets
Liquidity 67-12
short-term debt 26.7% · cash 21.8%
Profitability 100=
return on assets 24.8%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (5,413 companies, NACE 74, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.2%▲ +0.1 percentage points vs 10-2025highest value 12-2025: < 0.1%▼ -0.2 percentage points vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026lowest value 06-2026: < 0.1%● unchanged vs 05-2026lowest value 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: 0.1%▲ +0.1 percentage points vs 09-2026
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity ample (current ratio 3.75, compared with 3.04 in 2024, above the usual 1.5; short-term debt: 26.7% and cash: 21.8% of total assets), and 27.9% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 74, micro): better than 74% on solvency, 58% on liquidity, 76% on profitability and 80% on growth.

The bankruptcy probability was computed on 20-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Other professional, scientific and technical activities (NACE 74)
KBO
lowers risk · Liquidity: current ratio 3.75, cash €83,262
NBB · annual accounts
lowers risk · Equity €275,693 (72.1% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €382,568
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 31-10-2025, 0 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
on the day
2024
28 days late
2023
17 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 15 days after the deadline; the sector median (NACE 74) for financial year 2024 is 3 days before the deadline, and 38% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 31-03-2026 is due by 31-10-2026. Nothing is late today. The company usually files around 17 November (3 of the last 3 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
31-03-2026 year end21-10-2026 today31-10-2026 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2022.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Highest result from 2023 to 2025net €94,786 ▲0.7%
  3. Equity above €200,000equity €275,693 ▲52.4%

Financials · financial year 2025, micro format

Equity
€275,693▲ 52.4%
2024 · €180,907
Total assets
€382,568▲ 37.9%
2024 · €277,409
Net result
€94,786▲ 0.7%
2024 · €94,171
Working capital
€280,533▲ 50.7%
2024 · €186,141
Trend over the years

2023 to 2025, 3 financial years

The operating result has risen two years in a row; 2025 is 0% above 2024 and is the highest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€133,341 2025 Net result€94,786 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 74, Other professional, scientific and technical activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line202320242025
Operating result€114,921-€132,979▲ 15.7%€133,341▲ 0.3%
Net result€81,736above the sector's middle half-€94,171above the sector's middle half▲ 15.2%€94,786above the sector's middle half▲ 0.7%
Equity€86,736within the sector's middle half-€180,907above the sector's middle half▲ 109%€275,693above the sector's middle half▲ 52.4%
Total assets€158,415within the sector's middle half-€277,409above the sector's middle half▲ 75.1%€382,568above the sector's middle half▲ 37.9%
Debt€71,679-€96,502▲ 34.6%€106,875▲ 10.7%
Working capital€86,246above the sector's middle half-€186,141above the sector's middle half▲ 116%€280,533above the sector's middle half▲ 50.7%
Solvency54.8%within the sector's middle half-65.2%within the sector's middle half▲ 10.5pp72.1%within the sector's middle half▲ 6.9pp
Current ratio2.21within the sector's middle half-3.04within the sector's middle half▲ 0.833.75within the sector's middle half▲ 0.70
Return on assets (ROA)51.6%above the sector's middle half-33.9%above the sector's middle half▼ 17.6pp24.8%within the sector's middle half▼ 9.2pp
above within below the middle half of NACE 74, Other professional, scientific and technical activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €382,568
Equity €275,693 ▲ 52.4%
Debt €106,875 ▲ 10.7%
Debt's share of the balance-sheet total falls from 34.8% to 27.9%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€133,561▼
2024 · €133,729
Cash flow
€95,006▲
2024 · €94,921
Quick ratio
3.73▲
2024 · 3.02
Debt to equity
0.39▼
2024 · 0.53
ROE
34.4%▼
2024 · 52.1%
Interest coverage
88.80▼
2024 · over 100
Debt ≤ 1 year
€102,035▲
2024 · €91,048
Income taxes
€39,117=
2024 · €39,116
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 95.8% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.8% went bankrupt
2.3% stopped otherwise
95.8% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 42 lines
Balance sheet Code20242025
Assets
Total assets20/58€277,409€382,568▲
Fixed assets21/28€220-
Tangible fixed assets22/27€220-
Furniture and vehicles24€220-
Current assets29/58€277,189€382,568▲
Stocks and contracts in progress3€2,328€2,328=
Stocks30/36€2,328€2,328=
Amounts receivable within one year40/41€28,672€45,404▲
Trade receivables40€28,672€41,478▲
Other amounts receivable41-€3,926
Current investments50/53€150,108€251,424▲
Cash at bank and in hand54/58€95,931€83,262▼
Deferred charges and accrued income490/1€150€150=
Equity and liabilities
Total equity and liabilities10/49€277,409€382,568▲
Equity10/15€180,907€275,693▲
Contributions10/11€5,000€5,000=
Reserves13€175,907€270,693▲
Distributable reserves133€175,907€270,693▲
Amounts payable17/49€96,502€106,875▲
Amounts payable within one year42/48€91,048€102,035▲
Trade debts44€17,649€25,620▲
Suppliers440/4€17,649€25,620▲
Advances received on contracts in progress46€19,680€49,617▲
Taxes, remuneration and social security45€47,427€19,534▼
Taxes450/3€47,427€19,534▼
Other amounts payable47/48€6,292€7,264▲
Accrued charges and deferred income492/3€5,454€4,840▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€750€220▼
Other operating charges640/8€598€451▼
Gross operating margin9900€134,327€134,012▼
Operating profit (loss)9901€132,979€133,341▲
Financial income75/76B€759€2,066▲
Recurring financial income75€759€2,066▲
Financial charges65/66B€451€1,504▲
Recurring financial charges65€451€1,504▲
Profit (loss) for the period before taxes9903€133,287€133,903▲
Income taxes67/77€39,116€39,117=
Profit (loss) for the period9904€94,171€94,786▲
Profit (loss) for the period to be appropriated9905€94,171€94,786▲
Appropriation of the result
Profit (loss) to be appropriated9906€94,171€94,786▲
Transfer to equity691/2€94,171€94,786▲
To other reserves6921€94,171€94,786▲

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2,405€750€220▼ 70.7%
Other operating charges640/8€347€598€451▼ 24.6%
Gross operating margin9900€117,673€134,327€134,012▼ 0.2%
Operating profit (loss)9901€114,921€132,979€133,341▲ 0.3%
Financial income75/76B€1€759€2,066▲ 172%
Recurring financial income75€1€759€2,066▲ 172%
Financial charges65/66B€356€451€1,504▲ 233%
Recurring financial charges65€356€451€1,504▲ 233%
Profit (loss) for the period before taxes9903€114,566€133,287€133,903▲ 0.5%
Income taxes67/77€32,830€39,116€39,117=
Profit (loss) for the period9904€81,736€94,171€94,786▲ 0.7%
Profit (loss) for the period to be appropriated9905€81,736€94,171€94,786▲ 0.7%
Line202320242025Change
Assets
Total assets20/58€158,415€277,409€382,568▲ 37.9%
Fixed assets21/28€970€220--
Tangible fixed assets22/27€970€220--
Furniture and vehicles24€970€220--
Current assets29/58€157,445€277,189€382,568▲ 38.0%
Stocks and contracts in progress3€2,910€2,328€2,328=
Stocks30/36€2,910€2,328€2,328=
Amounts receivable within one year40/41€21,720€28,672€45,404▲ 58.4%
Trade receivables40€21,204€28,672€41,478▲ 44.7%
Other amounts receivable41€516-€3,926-
Current investments50/53-€150,108€251,424▲ 67.5%
Cash at bank and in hand54/58€132,773€95,931€83,262▼ 13.2%
Deferred charges and accrued income490/1€42€150€150=
Equity and liabilities
Total equity and liabilities10/49€158,415€277,409€382,568▲ 37.9%
Equity10/15€86,736€180,907€275,693▲ 52.4%
Contributions10/11€5,000€5,000€5,000=
Reserves13€81,736€175,907€270,693▲ 53.9%
Distributable reserves133€81,736€175,907€270,693▲ 53.9%
Amounts payable17/49€71,679€96,502€106,875▲ 10.7%
Amounts payable within one year42/48€71,199€91,048€102,035▲ 12.1%
Trade debts44€4,386€17,649€25,620▲ 45.2%
Suppliers440/4€4,386€17,649€25,620▲ 45.2%
Advances received on contracts in progress46€22,515€19,680€49,617▲ 152%
Taxes, remuneration and social security45€43,095€47,427€19,534▼ 58.8%
Taxes450/3€43,095€47,427€19,534▼ 58.8%
Other amounts payable47/48€1,203€6,292€7,264▲ 15.4%
Accrued charges and deferred income492/3€480€5,454€4,840▼ 11.3%
Line202320242025Change
Profit (loss) for the period9904€81,736€94,171€94,786▲ 0.7%
+ Depreciation and write-downs630€2,405€750€220▼ 70.7%
Operating cash flow (approximation)€84,141€94,921€95,006▲ 0.1%
Investment in fixed assets (approximation)-€0--
Change in cash--€36,842-€12,669▲ 65.6%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (3)
Financial year Type Filed Reference
31-03-2025 micro format 31-10-2025 2025-00560203
31-03-2024 micro format 28-11-2024 2024-00607053
31-03-2023 micro format 17-11-2023 2023-00513632

Similar companies · same sector, comparable size

Of the 4,499 active companies whose main activity is other professional, scientific and technical activities (NACE 74999), figures are known for 1,984. 1,417 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 0 of 1 Gazette act processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

ExMediKA was incorporated on 3 May 2022 as a private limited company.1 Total assets rose from €158,415 in 2023 to €382,568 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2023 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-10-2026
2025
31-10
NBB filing Annual accounts filed
financial year 2025 · micro format
31-03
Financial Highest result from 2023 to 2025net €94,786 ▲0.7%
Operating result €133,341, net result €94,786, both a record.
31-03
Financial Equity above €200,000equity €275,693 ▲52.4%
A profit in every financial year since 2023 builds equity to €275,693.
2024
28-11
NBB filing Annual accounts filed
financial year 2024 · micro format · 28 days late
31-03
Financial Equity above €150,000equity €180,907 ▲109%
A profit in every financial year since 2023 builds equity to €180,907.
2023
17-11
NBB filing Annual accounts filed
financial year 2023 · micro format · 17 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts

We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded03-05-2022
Financial year end31-03
Activities, NACEBEL 2025
74999Other professional, scientific and technical activities
47120Other non-specialised retail sale
47784Retail sale of souvenirs and religious articles
Contact
E-mail richirkarl@skynet.be
Phone +32497592112
Phone 0497592112Gesves
E-invoicing
Reachable via Peppol
Peppol ID 0208:0785643679
Registered 28-11-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 20 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Gesves · 1 establishment unit since 2022
registered office establishment The establishment unit on the map
Ground area
2,703 m²
Building footprint
333 m²
Parcel 92042D0196/00K004, Wallonia. Linked by address, not a title deed.
3 companies at this address See who is registered here
1 establishment unit
ExMedika
Drève des Arches 17, 5340 GesvesOther professional, scientific and technical activities
since 2022unit no. 2.330.950.184
1 parcel
Wallonia 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
92042D0196/00K004 Wallonia 2,703 m² 1 · 332 m² -
How the parcels are linked
Good to know
The parcel matches the address exactly.